Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Rutgers Research: Viral Hepatitis Can Be Eliminated If It Is a Top Priority

4/15/2016

0 Comments

 
​New Brunswick, NJ ― Viral hepatitis will only be eliminated in the United States if it is made a stronger priority, according to an interim report by the National Academies of Sciences, Engineering, and Medicine. 
 
Approximately 20,000 people die in the U.S. each year from viral hepatitis, often referred to as a “silent killer” and given significantly less attention than other potentially fatal diseases.
 
“These deaths could be averted,” said Brian L. Strom, M.D., the renowned epidemiologist who serves as Chancellor of Rutgers Biomedical and Health Sciences and heads a committee of scientists selected by the Academies to study the issue.  “The world has the tools to prevent hepatitis B and cure hepatitis C, which in turn could prevent most liver cancer.”
​“But the barriers to elimination of hepatitis B and C are consequences of a more basic problem – that viral hepatitis is simply not a public priority in the U.S.,” Strom said.
 
That could change soon. In May, the World Health Assembly will consider a resolution setting broad global targets of 90 percent reduction in the incidence of viral hepatitis and 65 percent reduction in its mortality by 2030.
 
“The United States has both an opportunity and a responsibility to be part of the global action against viral hepatitis,” Strom said. The committee’s report is summarized today in the Annals of Internal Medicine.
 
Hepatitis B virus (HBV) and hepatitis C virus (HCV) account for most of the world’s chronic viral hepatitis. HBV vaccine now results in 95 percent immunity, while new antiviral drugs can eliminate HCV infection in more than 90 percent of chronically infected patients, Strom explained.
 
“Taken together, these advances have encouraged global momentum for action against viral hepatitis,” Strom said.
 
While the committee’s next report in the spring of 2017 will recommend actions to eliminate viral hepatitis as a major U.S. health threat, Strom noted that the current barriers to doing so relate to logistics and cost.
 
“The HBV vaccine makes it possible to interrupt horizontal transmission of the virus, but ending transmission would require immunization of every susceptible person in a population,” he said. “As for hepatitis C, the costs of curative drugs have made this strategy impractical.”
 
The report said, "Because most cases are imported, U.S. support of vaccination efforts in other countries would be a wise investment in reducing the future burden of hepatitis B in the United States."
 
Complicating the issue is the fact that most people chronically infected with viral hepatitis are unaware of their condition.
 
The report notes that though eliminating viral hepatitis as a major health threat is a challenging goal, the committee believes the goal is attainable.
 
Rutgers Biomedical and Health Sciences (RBHS) is the way in education, research and clinical care.  It is one of only a few academic health centers in the U.S. with schools in medicine, dentistry, nursing, allied health, pharmacy, public health and biomedical science.
 
Integral to Rutgers University’s mission, RBHS works collaboratively with many other academic, research, and clinical units throughout the university and the region.  It is committed to a mission of excellence in biomedical and health care education, research, clinical care, and improving access to health care and reducing health disparities.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619